These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15826518)

  • 1. [Probable cardiac failure due to rofecoxib].
    García Nicolás FJ
    Aten Primaria; 2005 Apr; 35(6):325-6. PubMed ID: 15826518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute congestive heart failure induced by rofecoxib.
    Campbell RJ; Sneed KB
    J Am Board Fam Pract; 2004; 17(2):131-5. PubMed ID: 15082672
    [No Abstract]   [Full Text] [Related]  

  • 3. Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study.
    Hudson M; Richard H; Pilote L
    BMJ; 2005 Jun; 330(7504):1370. PubMed ID: 15947399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons on prescribing and drug safety from the withdrawal of rofecoxib.
    Nelson M; Cicuttini F
    Aust Fam Physician; 2004 Dec; 33(12):965-6. PubMed ID: 15630913
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous presentation of rofecoxib-induced acute hepatitis and acute interstitial nephritis.
    Haider M; Gain E; Khadem G; Pilmore H; Yun K; Jayasinghe N; Walker R
    Intern Med J; 2005 Jun; 35(6):370-2. PubMed ID: 15892770
    [No Abstract]   [Full Text] [Related]  

  • 6. COX-2 inhibitors and risk of heart failure.
    Kammerl MC; Debler J; Riegger GA; Krämer BK
    Lancet; 2004 Oct 23-29; 364(9444):1486-7; author reply 1487. PubMed ID: 15500886
    [No Abstract]   [Full Text] [Related]  

  • 7. Ten lessons to be learned from the withdrawal of Vioxx (rofecoxib).
    Carné X; Cruz N
    Eur J Epidemiol; 2005; 20(2):127-9. PubMed ID: 15792277
    [No Abstract]   [Full Text] [Related]  

  • 8. The great rofecoxib feeding frenzy.
    Van Way CW
    JPEN J Parenter Enteral Nutr; 2005; 29(2):136-8. PubMed ID: 15772394
    [No Abstract]   [Full Text] [Related]  

  • 9. [Extreme sinus bradycardia (30/min) with acute right heart failure under tizanidine (Sirdalud). Possible pharmacological interaction with rofecoxib (Vioxx)].
    Kick A; Bertoli R; Moschovitis G; Caduff Janosa P; Cerny A
    Med Klin (Munich); 2005 Apr; 100(4):213-6. PubMed ID: 15834531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probable rofecoxib-induced thrombocytopenia.
    Kentos A; Robin V; Lambermont M; Jurdan M; Pignarelli M; Feremans W
    Rheumatology (Oxford); 2003 May; 42(5):699-700. PubMed ID: 12709555
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse oral reactions associated with the COX-2 inhibitor rofecoxib.
    Bagán JV; Thongprasom K; Scully C
    Oral Dis; 2004 Nov; 10(6):401-3. PubMed ID: 15533219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study.
    Mamdani M; Juurlink DN; Lee DS; Rochon PA; Kopp A; Naglie G; Austin PC; Laupacis A; Stukel TA
    Lancet; 2004 May; 363(9423):1751-6. PubMed ID: 15172772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial hypertension induced by rofecoxib.
    Jacob S; Rajabally YA
    Headache; 2005 Jan; 45(1):75-6. PubMed ID: 15663617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gynecomastia secondary to rofecoxib].
    Martínez JA; Tejada González P; Gutiérrez Sanpedro N; González Blanco P
    Med Clin (Barc); 2002 Jun; 118(20):798-9. PubMed ID: 12049701
    [No Abstract]   [Full Text] [Related]  

  • 15. [Withdrawal of rofecoxib: a sign to be careful with coxibs in patients with increased cardiovascular risk].
    Bijlsma JW
    Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2162-4. PubMed ID: 15559407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe cholestasis and acute renal failure related to rofecoxib.
    Linares P; Vivas S; Jorquera F; Olcoz JL; de Leon B; Oritz de Urbina J
    Am J Gastroenterol; 2004 Aug; 99(8):1622-3. PubMed ID: 15307886
    [No Abstract]   [Full Text] [Related]  

  • 17. The Vioxx debacle.
    Alpert JS
    Am J Med; 2005 Mar; 118(3):203-4. PubMed ID: 15745713
    [No Abstract]   [Full Text] [Related]  

  • 18. Discontinuation of Vioxx.
    McLean TR
    Lancet; 2005 Jan 1-7; 365(9453):25; author reply 27-8. PubMed ID: 15639673
    [No Abstract]   [Full Text] [Related]  

  • 19. Lessons from the withdrawal of rofecoxib.
    Dieppe PA; Ebrahim S; Martin RM; Jüni P
    BMJ; 2004 Oct; 329(7471):867-8. PubMed ID: 15485938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation of Vioxx.
    Nutt DJ
    Lancet; 2005 Jan 1-7; 365(9453):28. PubMed ID: 15639676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.